INTRODUCTION
Body cavity fluids, including pleural, pericardial, and peritoneal fluids, present an important diagnostic opportunity for cytopathologists. Pleural effusions and peritoneal effusions (ascites) usually are collected using minimally invasive methods, and effusions often are drained for therapeutic reasons. These fluids may represent the first diagnosis of cancer in patients with an occult tumor, and an effusion may be an early sign of disease recurrence.
Although cytomorphology is the fundamental basis of a cytologic diagnosis, ancillary studies are playing a growing role in the workup of body fluid specimens. Immunohistochemical (IHC) stains on formalin-fixed, paraffin-embedded (FFPE) cell block sections are the most popular and readily available method and are the focus of this review. Specific applications of IHC include: 1) resolving the mesothelial or epithelial origin of isolated atypical cells and cell clusters; and 2) identifying the primary site of malignancy in a patient with a history of multiple malignancies or an unknown primary site. In all cases, the morphology, clinical history, and radiographic findings help guide the choice of ancillary studies to optimize small specimens and to reduce costs while providing the most diagnostically useful information. This review provides an overview of helpful ancillary methods and tips for approaching challenging cases.
Preanalytic Issues and Specimen Preparation for Ancillary Studies
We recommend upfront preparation of a FFPE cell block whenever the specimen has adequate volume and cellularity. In our practice, this is determined by the judgement of the cytopreparatory technician based on the Cancer Cytopathology August 2018 volume and turbidity of the specimen, as well as whether a sufficient cell button is formed after centrifugation of the fluid. One group has suggested a minimum fluid volume of 60 to 75 mL for the adequate evaluation of fluids. 1, 2 Creating a cell block upfront reduces any delay should IHC be needed and decreases the number of times the specimen needs to be stored and located in the cytopreparatory workflow.
Several cell block preparations are available, each with distinct advantages and limitations [3] [4] [5] ; a detailed discussion is beyond the scope of this review. Important considerations when choosing a cell block technique include the cost, workflow impact, technical skill required, scalability, cellular yield, preservation of cytomorphology, and performance with IHC stains.
Cell block preparation provides a means of concentrating paucicellular specimens and may capture larger tissue fragments. Cut sections of a cell block may reveal the internal structure of thick, 3-dimensional groups (eg, fibrovascular cores, hollow "cannon ball" spheres, solid cellular groups, or psammomatous calcifications). In larger cellular groups and tissue fragments, cell blocks also may improve the visualization of nuclear and cytoplasmic features. When ordering an initial panel of IHC stains on a cell block, cutting extra unstained slides upfront may be helpful for conserving small cell block specimens to reduce the amount of specimen loss due to multiple block facings. An initial batch of 10 unstained slides usually is sufficient for a diagnostic workup in all but the most challenging cases. For thoracic specimens and other specimens likely to require subsequent molecular or other biomarker testing, 15 unstained slides may be considered.
Preparation of additional cytospin slides, ThinPrep (Hologic, Marlborough, Massachusetts) or SurePath (Becton, Dickinson and Company, Franklin Lakes, New Jersey) slides, or smears for immunocytochemistry or fluorescence in situ hybridization (FISH) can be an alternative or adjunct to cell blocks. These tests should be validated as appropriate for the specimen type, fixation conditions, and cytologic preparation, or a disclaimer added to the interpretation.
Specific Applications of Ancillary Studies
An overview of an algorithm for the workup of challenging effusions is presented in Fig. 1 6 Using a prostate carcinoma triple stain, one slide can be used to assess simultaneously for the presence of alpha-methylacyl-CoA racemase (AMACR) in adenocarcinoma and the intactness of the basal layer. 7 In effusion cytology, the Wilms tumor 1/ AE1/AE3 cytokeratin (CK) (WT1/AE1/AE3) dual stain is a multipurpose tool for colocalizing the expression of these 2 proteins within the same cells. WT1 is a transcriptional regulator used for its nuclear staining in benign mesothelial cells and malignant mesothelioma; it also is expressed in the nuclei of serous neoplasms (see later discussion of BRCA1-associated protein 1 [BAP1]), but the majority of other carcinomas are negative (Fig.  2) .
8 AE1/AE3 is a CK antibody that highlights the cytoplasm of both epithelial cells and mesothelial cells. Thus, dual staining with WT1/AE1/AE3 distinguishes cells of mesothelial origin from the majority of epithelial cells, 8 which is particularly useful when clusters of cells with indeterminate morphology are observed on the cell block. The dual stain is ideally implemented with different chromogens for WT1 and AE1/AE3 (eg, a brown chromogen for WT1 and a red chromogen for AE1/AE3). This dual stain has 2 additional diagnostic uses: cytoplasmic staining for WT1 is characteristic of melanoma and some sarcomas, 8 and AE1/AE3 demonstrates a weak, perinuclear "dot-like" pattern in small cell carcinoma. 9 In the majority of cases, this stain is sufficient on its own to differentiate mesothelial from epithelial cells, and to identify background macrophages by negative staining.
Additional stains for mesothelial differentiation
Of single stains for mesothelial origin, WT1 combines high specificity with good sensitivity, with positive staining reported in approximately 70% to 95% of cases with cells of mesothelial origin.
10,11 However, in cases in which
Cancer Cytopathology August 2018 mesothelial origin is suspected but WT1 is negative or equivocal, a panel of additional markers may be useful. Other markers that have lower specificity and may stain some adenocarcinomas include calretinin (nuclear and cytoplasmic), D2-40 (also known as podoplanin; membranous pattern), and mesothelin (membranous).
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Claudin 4
Claudin 4 is a tight junction-associated protein, 12 and staining for claudin 4 now is a preferred pan-adenocarcinoma marker. A positive result demonstrates crisp membranous staining (Fig. 2) . Claudin 4 shows improved sensitivity and specificity over Ber-EP4 and MOC-31 for distinguishing adenocarcinoma from cells of mesothelial origin. [13] [14] [15] Although Ber-EP4 and MOC-31 are reasonably sensitive as adenocarcinoma markers, both demonstrate positive staining in a subset of epithelioid mesotheliomas, which represents a potential diagnostic pitfall in effusion specimens. 14, 15 A study found no membranous staining in 75 malignant mesotheliomas, although 11% (8 of 75 cases) had weak cytoplasmic staining, which is considered nonspecific. 12 In our practice, we no longer routinely use Ber-EP4 or MOC-31 because we have found claudin 4 to be more useful. In laboratories in which claudin 4 is not available, Ber-EP4 and MOC-31 still are of use, perhaps together with a mesothelial marker such as WT1 when malignant mesothelioma enters the differential diagnosis.
BAP1, a new marker that is helpful in distinguishing reactive mesothelial cells from malignant mesothelioma
The distinction between reactive and malignant mesothelial cells has long been a challenge in effusion cytology. In biopsy specimens, pleural invasion aids in the diagnosis of malignant mesothelioma; however, in cytologic specimens, in which invasion per se cannot be assessed, malignant mesothelioma is difficult to diagnose with certainty, except perhaps when a patient with a robust asbestos exposure history, recurrent pleural effusions, and characteristic radiographic findings has a clearly malignant effusion with abundant large ("mulberry-like") cell Cancer Cytopathology August 2018 clusters with a mesothelial immunophenotype. Until recently, epithelial membrane antigen was perhaps the best marker for distinguishing benign mesothelial cells from malignant mesothelioma, but some studies reported a lower sensitivity. 16 Thus, it was not widely used for this purpose. In addition, the specificity of epithelial membrane antigen staining varies by the specific antibody clone that is used. Other markers, such as desmin and glucose transporter type 1 (GLUT-1), also have been proposed to distinguish between benign and malignant mesothelial cells, but significant overlap between the 2 has been demonstrated, and therefore these markers do not provide sufficient specificity for clinical practice. 10, 16 A big step forward was the recent availability of the BAP1 immunostain, a relatively new marker that is expressed in the nuclei of benign mesothelial cells but is absent in greater than one-half of cases of malignant mesothelioma. 17 The BAP1 gene is located at 3p21, which is lost in approximately 30% of mesotheliomas. 17 Including mesotheliomas with BAP1 truncations and other mutations, approximately 60% to 79% of mesotheliomas have genetic alterations in BAP1. 17 Accordingly, IHC staining for BAP1 is lost in a substantial subset of malignant mesotheliomas but retained in benign mesothelial proliferations, and its performance correlates well with 9p21 FISH (p16 deletion). 18, 19 It is important to note that patchy BAP1 staining may be noted in benign and reactive mesothelial populations, and thus caution should be observed when making an interpretation of BAP1 loss in effusion specimens containing rare atypical cells. 20 Special attention should be paid to background inflammatory cells, an essential internal control for BAP1 staining (Fig. 3) . A major differential diagnostic consideration within the context of malignant mesothelioma is serous carcinoma of the gynecologic tract, both of which are WT1 positive. BAP1 is retained in nearly all serous carcinomas, 21 making it a useful addition to a panel to differentiate between malignant mesothelioma and serous carcinoma, which also could include calretinin (usually positive in mesothelial cells) and paired box 8 (PAX8) (usually positive in serous carcinoma), as discussed in more detail below.
Additional studies to differentiate reactive mesothelial cells from malignant mesothelioma
In addition to the aforementioned IHC stains, several nucleic acid-based tests are available for the diagnosis of malignant mesothelioma. These include conventional cytogenetics (requiring the allocation of fresh specimen 
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for culture), FISH, UroVysion (Abbott Molecular Inc, Des Plaines, Illinois), and comparative genomic hybridization arrays. [22] [23] [24] [25] The combination of karyotyping and 9p21 and 22q deletions by FISH in patients with malignant mesothelioma detected diagnostic abnormalities in approximately 54% of patients (13 of 24 patients), including 8 whose specimens were negative or suspicious for malignant mesothelioma on cytology. 22 Potential pitfalls include the confirmation of the mesothelial origin of the cells of interest, because other malignancies may share these chromosomal alterations.
Workup of Malignant Effusions to Determine Site of Origin
The most cost-effective "studies" for the initial evaluation of malignant effusions are a thorough review of the clinical history and radiographic findings and cytomorphologic examination of the fluid. A personal history of malignancy is a key consideration in guiding the diagnostic workup. Additional detailed history might include a history of carcinogenic exposures (eg, tobacco use or asbestos exposure), symptoms and signs indicating a possible primary tumor localization (eg, melena), and a family history of malignancy. A high level of clinical concern for a specific primary site may lower the threshold for ordering confirmatory IHC stains. A discussion of specific IHC workup strategies by effusion site follows.
Morphologic evaluation of the fluid may suggest a particular lineage or differential diagnosis. Mesothelial features such as microvillous "lacy skirt" borders, windows between adjacent cells, and multinucleation suggest mesothelial origin and allow targeting of the IHC panel. Isolated atypical cells may represent reactive mesothelial cells, mesothelioma, adenocarcinoma, melanoma, lymphoma, or less common entities such as metastatic sarcoma. 
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Pleural and pericardial effusions In men, the most frequent causes of malignant pleural effusions are lung carcinoma, lymphoma/leukemia, and gastrointestinal carcinoma. 26 In women, breast carcinoma is the most frequent cause (although malignant pleural effusions very rarely are the initial presentation of breast cancer), followed by lung carcinoma and lymphoma/leukemia. 26 Lung adenocarcinoma usually can be identified through positive IHC staining for thyroid transcription factor 1 (TTF-1) and napsin A, with a few important caveats. Mucinous lung adenocarcinoma may lack both TTF-1 and napsin A expression 27 and, in such cases, a metastasis from another site such as the gastrointestinal tract should be considered. TTF-1 is not entirely specific for lung origin. It also is expressed in most thyroid malignancies (including medullary thyroid carcinomas), but it is rare for a thyroid malignancy to present clinically as a malignant effusion of unknown primary. A minority of endometrial and endocervical carcinomas also are strongly positive for TTF-1. 28 In women, breast carcinoma is an important consideration with pleural fluids and, less often, pericardial fluids. Metastatic breast carcinoma in effusions often forms "cannonball" spheres, which may be hollow on cell block preparations. 26 A useful IHC panel for breast origin includes GATA-binding protein 3 (GATA3) and mammaglobin. Estrogen receptor (ER) should be used cautiously as a diagnostic stain in patients with known ER-positive breast carcinoma. Other malignancies can be ER positive, including carcinomas of Mullerian origin, lung adenocarcinoma, and papillary thyroid carcinoma. 29 However, the biomarkers ER, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) can be performed on effusion specimens for the prediction of clinical therapeutic response. 30 
Peritoneal effusions
In men, the most common causes of malignant peritoneal effusions are lymphoma/leukemia, gastrointestinal carcinoma, and pancreatic carcinoma. 26 In women, the most common causes of malignant peritoneal effusions are carcinomas of the gynecologic tract, breast carcinoma, and gastric carcinoma. 26 In the workup of a potential gastrointestinal primary site, CK7 and CK20 should be interpreted with caution because mesothelial cells are strongly positive for CK7. It may be helpful to compare these stains with staining for a mesothelial marker such as WT1 or calretinin as well as claudin 4 to determine the percentage and distribution of mesothelial cells and adenocarcinoma. More specific stains for gastrointestinal origin such as caudal type homeobox 2 (CDX2) or SATB homeobox 2 (SATB2) may be included. The differential diagnosis between mesothelial cells and a serous neoplasm often is straightforward. Although mesothelial cells and serous neoplasms both demonstrate nuclear WT1 expression (Fig. 1) , serous neoplasms usually lack other mesothelial markers (calretinin and D2-40) and express PAX8 (nuclear staining) and claudin 4 (membranous staining), which usually are absent in mesothelial cells. It is interesting to note that PAX8 also is expressed in carcinomas of renal and thyroid origin. 29 If malignant mesothelioma is in the morphologic and clinical differential diagnosis, BAP1 may be added to the panel. 21 
Effusions With Increased Lymphocytes or Other Hematolymphoid Cells
In fluids containing increased numbers of hematolymphoid cells, correlation of cytologic preparations with peripheral counts as well as fluid cell counts and slide preparations in the hematology laboratory may help in triaging the fluid appropriately and in providing consistent reporting across the laboratory. In effusions containing distinctive populations of lymphocytes and plasma cells, flow cytometry can be a very useful diagnostic study. Flow cytometry can be performed only on the fresh specimen, before alcohol or formalin fixation. A limited hematologic workup can be performed on a cell block specimen, including CD3 and CD20, with targeted B-cell or T-cell panels to follow. 31 Unstained levels from the cell block, ThinPrep or SurePath slides, or unstained cytospin slides prepared directly from the fluid may be used for subsequent FISH testing.
A pleural effusion occurs in approximately 20% to 30% of patients with lymphoma, both Hodgkin and non-Hodgkin types. 31 The majority of patients have a known history of lymphoma or a known predisposing condition, such as human immunodeficiency virus infection, which can aid greatly in targeting the workup. 31 Lymphomatous ascites and pericardial effusions are less common. When lymphoma is suspected, a cell block should be prepared in addition to flow cytometry, if there is sufficient specimen. Diffuse large B-cell lymphoma may be difficult to characterize on flow cytometry, and the neoplastic cells of Hodgkin lymphoma typically are rare, leading to negative results. If large Reed-Sternberglike cells are identified on the cell block, appropriate IHC workup including CD30, CD15, BOB1, and octamer transcription factor-2 (OCT2) can be performed. Primary effusion lymphoma is a rare large-cell lymphoma
Cancer Cytopathology August 2018 most often associated with human immunodeficiency virus together with human herpesvirus 8 viral infection. 31 Morphologically, primary effusion lymphoma is a large B-cell lymphoma with a plasmablastic, immunoblastic, or anaplastic appearance. 26 On flow cytometry, the cells usually are positive for CD45 and negative for the majority of B-cell markers. The cells may express activation-associated antigens, such as human leukocyte antigen-antigen D related (HLA-DR), and sometimes are identified by aberrant T-cell marker expression. 32 The detection of human herpesvirus 8 viral infection, which may be performed by IHC staining of a cell block, is essential to the diagnosis. 32 Eosinophil-rich pleural effusions are not infrequent; the most common cause is pneumothorax (spontaneous or iatrogenic), although Churg-Strauss syndrome is a potential consideration. 26 The presence of increased eosinophils within a background of mixed inflammatory cells may raise concern for Hodgkin lymphoma, in which IHC staining as described in the above paragraph may be of use. Langerhans cell histiocytosis is exceptionally rare in pleural fluids.
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Molecular and Biomarker Testing in Effusion Specimens
Effusion cytology specimens are a valuable resource for molecular testing. Smears, cytospin preparations, liquidbased preparation slides, and cell blocks all can be used for molecular testing. FFPE cell blocks fit easily into existing workflows built around FFPE surgical tissue. However, alcohol-fixed or air-dried and stained cytology slides can be scraped and used for molecular testing, and may yield higher quality nucleic acid due to the lack of formalin crosslinking artifacts. 34 Appropriate validation of molecular tests for the cytologic preparation and fixative type is important, particularly because the amount of input DNA may need to be adjusted. In selected cases, it may be helpful to reserve a portion of the fresh specimen for prompt nucleic acid extraction and next-generation sequencing to avoid the damage to nucleic acids caused by formalin fixation. Effusions with even low to moderate tumor quantity can be used for next-generation sequencing and for single-gene tests, although a low percentage of tumor in relation to background mesothelial or inflammatory elements may be limiting. 35 Anaplastic lymphoma kinase (ALK) and reactive oxygen species 1 (ROS1) IHC stains may be useful in specimens with a low tumor percentage because the counterstain affords morphologic identification of tumor cells. ALK has been particularly well studied in cytology specimens. 36 ALK IHC staining is acceptable as an alternative to FISH, as per the College of American Pathologists guideline for molecular testing in patients with lung cancer. 37 However, ROS1 IHC staining should be confirmed by follow-up FISH or a molecular method. 37 Programmed death-ligand 1 (PD-L1) has been reported in cytology specimens containing ≥100 well-preserved tumor cells, with good concordance with surgical specimens. 38 To the best of our knowledge, there are very few data to date regarding reporting PD-L1 in specimens that contain <100 well-preserved tumor cells. Thus, PD-L1 should be interpreted cautiously in specimens with low cellularity. If PD-L1 is reported in lower cellularity specimens, an explanatory note should indicate that the interpretation might be limited by the low cellularity. Because of the clinical importance of predictive biomarkers, the College of American Pathologists guidelines for validation of these biomarkers are more stringent than those for other stains.
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Conclusions
Pleural, pericardial, and peritoneal effusions are challenging yet highly clinically useful specimens for the initial diagnosis of malignancy and the early identification of disease recurrence in patients with cancer. The morphologic evaluation of effusion specimens has been greatly enhanced recently by the addition of new IHC stains that help with morphologically ambiguous fluids. Targeted panels of IHC stains in combination with clinical and morphologic features provide more specific diagnoses than ever before, which may eliminate the need for more invasive tissue sampling. In addition, cytology slides and cell block preparations may be used for molecular and other biomarker testing. These opportunities continue to shape the cytopathologist's role as a minimally invasive diagnostician in the era of precision medicine.
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